CILOSTAZOL INCREASES PATENCY AND DECREASES ADVERSE OUTCOMES IN PATIENTS SUBMITTED TO PERCUTANEOUS FEMOROPOPLITEAL STENT REVASCULARIZATION: A RANDOMIZED CONTROLLED TRIALS META-ANALYSIS Article
Full Text via DOI: 10.1016/S0735-1097(14)62056-8
Web of Science: 000359579102811